Your browser doesn't support javascript.
loading
Prognostic impact of bone metastases detected by 18F-DOPA PET in patients with metastatic midgut neuroendocrine tumors.
Deleval, Nicolas; Pesque, Louise; Dieudonné, Arnaud; Viry, Flore; Hentic, Olivia; Lebtahi, Rachida; Ruszniewski, Philippe; de Mestier, Louis.
Afiliação
  • Deleval N; Department of Nuclear Medicine, ENETS Centre of Excellence, Beaujon Hospital (APHP), Clichy, France.
  • Pesque L; Université de Paris, Paris, France.
  • Dieudonné A; Department of Nuclear Medicine, ENETS Centre of Excellence, Beaujon Hospital (APHP), Clichy, France.
  • Viry F; Université de Paris, Paris, France.
  • Hentic O; Department of Nuclear Medicine, ENETS Centre of Excellence, Beaujon Hospital (APHP), Clichy, France.
  • Lebtahi R; Department of Radiology, Lariboisière Hospital (APHP), Paris, France.
  • Ruszniewski P; Department of Gastroenterology and Pancreatology, ENETS Centre of Excellence, Beaujon Hospital (APHP), 100 boulevard du Général Leclerc, 92110, Clichy, France.
  • de Mestier L; Department of Nuclear Medicine, ENETS Centre of Excellence, Beaujon Hospital (APHP), Clichy, France.
Eur Radiol ; 31(6): 4166-4174, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33247341

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Di-Hidroxifenilalanina / Tumores Neuroendócrinos Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Di-Hidroxifenilalanina / Tumores Neuroendócrinos Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article